January 5, 2023 January 5, 2023Categories Ongoing TrialsOngoing Trial: The INSPIRE research study is testing a new treatment approach for patients with advanced bladder cancerThis trial is evaluating the effect of adding immune system therapy to the usual treatment (chemotherapy and radiation)
January 5, 2023 January 5, 2023Categories Ongoing TrialsOngoing Trial: The INSIGNA clinical trial is testing the timing of immunotherapy alone or with chemotherapy for patients with advanced lung cancerThis trial is seeking to find out whether patients with the PD-L1 biomarker can either delay having chemotherapy or avoid it altogether
January 5, 2023 January 5, 2023Categories Trial ResultsTrial Results: A recent ECOG-ACRIN study finds excellent results for patients with acute lymphoblastic leukemia (ALL)Adding immunotherapy to standard chemotherapy keeps most patients in remission and improves their survival
September 26, 2022 September 26, 2022Categories New TrialsNow Enrolling: The EA2205 research study is testing a new treatment approach for a rare form of liver cancerResearchers at ECOG-ACRIN are studying if they can improve results for patients with liver cancer by giving chemotherapy along with drugs that help the body’s immune system fight cancer